Details for New Drug Application (NDA): 021814
✉ Email this page to a colleague
The generic ingredient in APTIVUS is tipranavir. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the tipranavir profile page.
Summary for 021814
Tradename: | APTIVUS |
Applicant: | Boehringer Ingelheim |
Ingredient: | tipranavir |
Patents: | 0 |
Pharmacology for NDA: 021814
Mechanism of Action | HIV Protease Inhibitors |
Suppliers and Packaging for NDA: 021814
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
APTIVUS | tipranavir | CAPSULE;ORAL | 021814 | NDA | Boehringer Ingelheim Pharmaceuticals, Inc. | 0597-0003 | 0597-0003-02 | 120 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC (0597-0003-02) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 250MG | ||||
Approval Date: | Jun 22, 2005 | TE: | RLD: | Yes |
Expired US Patents for NDA 021814
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Boehringer Ingelheim | APTIVUS | tipranavir | CAPSULE;ORAL | 021814-001 | Jun 22, 2005 | ⤷ Sign Up | ⤷ Sign Up |
Boehringer Ingelheim | APTIVUS | tipranavir | CAPSULE;ORAL | 021814-001 | Jun 22, 2005 | ⤷ Sign Up | ⤷ Sign Up |
Boehringer Ingelheim | APTIVUS | tipranavir | CAPSULE;ORAL | 021814-001 | Jun 22, 2005 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription